# FDA recall D-569-2014

> **Aidapak Services, LLC** · Class II · drug recall initiated 2013-07-02.

## Product

guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45802049878

## Reason for recall

Labeling: Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: AD21790_52, EXP: 5/1/2014;  FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: W002733, EXP: 6/6/2014;  glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: W003688, EXP: 5/31/2014;  glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: AD30140_34, E

## Distribution

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

## Key facts

- **Recall number:** D-569-2014
- **Recalling firm:** Aidapak Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-02
- **Report date:** 2014-01-22
- **Termination date:** 2014-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vancouver, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-569-2014

## Citation

> AI Analytics. FDA recall D-569-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-569-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*